Madelyn Espinosa-Cotton

Research Associate at MSKCC developing immunotherapy and radioimmunotherapy for DSRCT

[Madelyn Espinosa-Cotton @906Madelyn]

Thanks to @MSKLibrary for featuring our recently published work:
Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with... https://t.co/mkBXCINMBW

[Frontiers - Oncology @FrontOncology]

📄 How can immunotherapy be used to treat desmoplastic small round cell tumor?

👨‍⚕️👩‍⚕️ Madelyn Espinosa-Cotton et al.

Available here #OpenAccess 👉 https://t.co/kaIvK0pdnb

[Nathan Reticker-Flynn @RetickerFlynn]

Tumors spread to lymph nodes before they metastasize to distant tissues, but for over a century scientists have debated whether this matters. It does. Check out our paper online now @CellCellPress @CellPressNews
https://t.co/WLPnoPtFhN

1/15

[Lucas Karas @lucaskaras1]

The story of today 😅

[Madelyn Espinosa-Cotton @906Madelyn]

@OptimumHelp You’re really sending technicians into people’s homes in the middle of a pandemic without masks? My husband just had to ask your technician to put a mask on and the technician didn’t even have one with him. We gave him one to wear and take with him to his next appt.

[Madelyn Espinosa-Cotton @906Madelyn]

The cancer research community lost a giant today.

[AACR @AACR]

José Baselga, MD, PhD— revered AACR Past President, Fellow of the AACR Academy, and an internationally renowned expert in the development of molecular targeted agents— has died at the age of 61. We offer heartfelt condolences to his family, colleagues, and friends.
#AACRFellows

[Alex Loves UX @alexlovesux]

“6 things wrong with NYC’s ballot design” by Alexander Cotton
https://t.co/h1i232s2EW

#ballotdesign #civicdesign #voting #Election2020 #vote2020 #ux #userexperience #nyc

[Madelyn Espinosa-Cotton @906Madelyn]

https://t.co/c6t2GUhCOJ

[Andy Slavitt 🇺🇦 @ASlavitt]

COVID UPDATE July 13: There are successful examples of taking on COVID-19.

And there is one story like no others. New York. 1/